findmyKOL
Clinical trialNCT01142089CompletedPhase 3Interventional

Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)

SponsorCosmo Technologies LtdEnrollment264Traveler's Diarrhea
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Guatemala
  • Santarus Investigational Site 03

    Antigua Guatemala, Guatemala

  • Santarus Investigational Site 14

    Antigua Guatemala, Guatemala

  • Santarus Investigational Site 04

    Quetzaltenango, Guatemala

Mexico
  • Santarus Investigational Site 05

    Guadalajara, Jalisco, Mexico

  • Santarus Investigational Site 06

    Cuernavaca, Morelos, Mexico

  • Santarus Investigational Site 12

    Cabo San Lucas, Mexico

  • Santarus Investigational Site 10

    Cancún, Mexico

  • Santarus Investigational Site 07

    Oaxaca City, Mexico

  • Santarus Investigational Site 08

    Puebla City, Mexico

  • Santarus Investigational Site 09

    Puerto Escondido, Mexico

  • Santarus Investigational Site 11

    Puerto Vallarta, Mexico

  • Santarus Investigational Site 13

    Tulum, Mexico

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 May 2010
Primary completion
30 Jun 2012
Completion
30 Jun 2012
Last update posted
8 Jun 2018
Registered enrollment
264
Registry id
NCT01142089

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.